Heron Therapeutics, Inc. (HRTX)
0.4061
+0.05
(+13.37%)
USD |
NASDAQ |
Oct 09, 16:00
0.4049
0.00 (0.00%)
Pre-Market: 20:00
Heron Therapeutics Cash from Operations (Quarterly) : -2.213M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.213M |
| March 31, 2026 | -1.54M |
| December 31, 2025 | -9.184M |
| September 30, 2025 | 1.331M |
| June 30, 2025 | -10.87M |
| March 31, 2025 | -8.87M |
| December 31, 2024 | -11.78M |
| September 30, 2024 | 3.371M |
| June 30, 2024 | -4.604M |
| March 31, 2024 | -9.516M |
| December 31, 2023 | 2.455M |
| September 30, 2023 | -9.179M |
| June 30, 2023 | -27.16M |
| March 31, 2023 | -24.90M |
| December 31, 2022 | -37.53M |
| September 30, 2022 | -37.07M |
| June 30, 2022 | -28.37M |
| March 31, 2022 | -43.94M |
| December 31, 2021 | -45.26M |
| September 30, 2021 | -53.17M |
| June 30, 2021 | -62.99M |
| March 31, 2021 | -41.94M |
| December 31, 2020 | -52.55M |
| September 30, 2020 | -42.05M |
| June 30, 2020 | -57.28M |
| Date | Value |
|---|---|
| March 31, 2020 | -32.94M |
| December 31, 2019 | -26.98M |
| September 30, 2019 | -25.47M |
| June 30, 2019 | -23.11M |
| March 31, 2019 | -49.02M |
| December 31, 2018 | -33.49M |
| September 30, 2018 | -35.88M |
| June 30, 2018 | -60.73M |
| March 31, 2018 | -61.71M |
| December 31, 2017 | -47.15M |
| September 30, 2017 | -40.54M |
| June 30, 2017 | -32.03M |
| March 31, 2017 | -50.58M |
| December 31, 2016 | -38.52M |
| September 30, 2016 | -36.12M |
| June 30, 2016 | -27.11M |
| March 31, 2016 | -32.35M |
| December 31, 2015 | -23.15M |
| September 30, 2015 | -19.89M |
| June 30, 2015 | -15.82M |
| March 31, 2015 | -19.67M |
| December 31, 2014 | -12.86M |
| September 30, 2014 | -19.24M |
| June 30, 2014 | -12.48M |
| March 31, 2014 | -15.71M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -41.87M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
| Savara, Inc. | -29.75M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -3.265M |
| Cash from Financing (Quarterly) | 0.082M |
| Free Cash Flow | -12.14M |
| Free Cash Flow Per Share (Quarterly) | -0.0124 |
| Free Cash Flow to Equity (Quarterly) | -9.071M |
| Free Cash Flow to Firm (Quarterly) | -2.351M |
| Free Cash Flow Yield | -16.19% |